Stock CHRS COHERUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
1.8 USD +9.09% Intraday chart for Coherus BioSciences, Inc. +24.14% -45.95%
Jul. 15 Hanall Biopharma Co., Ltd. Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer CI
Jul. 02 Coherus BioSciences Grants Apotex License to Distribute Toripalimab in Canada MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
COHERUS BIOSCIENCES, INC.
Bio Therapeutic Drugs
+9.09%+24.14%-45.95%-55.67%-90.28% 189M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. CHRS Stock
  4. Charts Coherus BioSciences, Inc.
  5. Relative Strength Chart